Optimization of CRBN Ligand and Linker Drives Discovery of APH003, an Orally Bioavailable IRAK4 PROTAC DegraderAugust 11, 2026
Unlocking Direct C–S Bonds: Radical C–SuFEx Ligation of Sulfonyl and Sulfonimidoyl Fluorides with Alkenes and AlkynesJune 2, 2026
Oxetane as a Strategic Bioisostere: Improving ADMET Profiles and Pharmacokinetics in Small Molecule DesignMay 29, 2026
PROTAC Technology Enters Its Commercialization Era: Key Molecular Building Blocks for Your Next BreakthroughMay 21, 2026